Literature DB >> 7608535

Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1.

E A Clark1, K H Grabstein, A M Gown, M Skelly, T Kaisho, T Hirano, G L Shu.   

Abstract

Previously, we described the characteristics of a cell line that is derived from a low density fraction of human tonsillar cells and, on the basis of a number of criteria, is related to follicular dendritic cells (FDC). This line, FDC-1, binds B lymphocytes and not T lymphocytes, and promotes anti-Ig- or anti-CD40-induced B cell proliferation. In this work, we show that culturing B cells with small numbers of FDC-1 cells leads to significant production of IL-6 and of both IgM and IgG. As few as 50 to 100 FDC-1 augmented B cell IgM production by 10- to 100-fold. Although fixed FDC-1 cells, unlike live FDC-1 cells, do not stimulate Ig production, cell contact is not required for all FDC-dependent Ig production. Supernatants from cultured FDC-1 cells can also stimulate B cells to produce IgM, suggesting that FDC produce a soluble B cell stimulating factor(s). Augmentation of FDC-dependent IgM production by either IL-6 or IL-7 and augmentation of FDC-dependent IgG production by IL-4 does require FDC-1 cells to be in contact with B cells. When the effects of FDC-1 cells were compared with those of epithelial cell lines and human foreskin fibroblasts (HFF), both FDC-1 cells and HFF induced B cells to produce IgM. FDC-1, unlike HFF, were positive for CD40, CD54, CD73, CD74, and nerve growth factor receptor (NGFR), and unlike HFF, but like certain stromal cells, FDC-1 cells also expressed smooth muscle actin, and a novel marker for stromal cells, BST-1. The possible relationship of FDC-1 cells and FDC in general to a fibroblast/stromal cell lineage is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection.

Authors:  Z Q Zhang; T Schuler; W Cavert; D W Notermans; K Gebhard; K Henry; D V Havlir; H F Günthard; J K Wong; S Little; M B Feinberg; M A Polis; L K Schrager; T W Schacker; D D Richman; L Corey; S A Danner; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.

Authors:  Haijing Sun; Xiaofan Mi; Nan Gao; Chenxi Yan; Fu-Shin Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 3.  The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.

Authors:  Bertrand Allard; Maria Serena Longhi; Simon C Robson; John Stagg
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

4.  Platelet-activating factor antagonists decrease follicular dendritic-cell stimulation of human B lymphocytes.

Authors:  Isaac Halickman; Yolande Bastien; Qianli Zhuang; Monty B Mazer; Baruch Toledano; Bruce D Mazer
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

5.  Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells.

Authors:  Y Shimaoka; J F Attrep; T Hirano; K Ishihara; R Suzuki; T Toyosaki; T Ochi; P E Lipsky
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

6.  Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Natalia A Castillo; Gabriela Perdigón; Alejandra de Moreno de Leblanc
Journal:  BMC Microbiol       Date:  2011-08-03       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.